Literature DB >> 18723673

Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.

Peter J Campbell1, Erin D Pleasance, Philip J Stephens, Ed Dicks, Richard Rance, Ian Goodhead, George A Follows, Anthony R Green, P Andy Futreal, Michael R Stratton.   

Abstract

During the clonal expansion of cancer from an ancestral cell with an initiating oncogenic mutation to symptomatic neoplasm, the occurrence of somatic mutations (both driver and passenger) can be used to track the on-going evolution of the neoplasm. All subclones within a cancer are phylogenetically related, with the prevalence of each subclone determined by its evolutionary fitness and the timing of its origin relative to other subclones. Recently developed massively parallel sequencing platforms promise the ability to detect rare subclones of genetic variants without a priori knowledge of the mutations involved. We used ultra-deep pyrosequencing to investigate intraclonal diversification at the Ig heavy chain locus in 22 patients with B-cell chronic lymphocytic leukemia. Analysis of a non-polymorphic control locus revealed artifactual insertions and deletions resulting from sequencing errors and base substitutions caused by polymerase misincorporation during PCR amplification. We developed an algorithm to differentiate genuine haplotypes of somatic hypermutations from such artifacts. This proved capable of detecting multiple rare subclones with frequencies as low as 1 in 5000 copies and allowed the characterization of phylogenetic interrelationships among subclones within each patient. This study demonstrates the potential for ultra-deep resequencing to recapitulate the dynamics of clonal evolution in cancer cell populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723673      PMCID: PMC2529122          DOI: 10.1073/pnas.0801523105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Methods for determining spontaneous mutation rates.

Authors:  Patricia L Foster
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 2.  The origin of B-cell chronic lymphocytic leukemia.

Authors:  Paolo Ghia; Federico Caligaris-Cappio
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

3.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

4.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

5.  Escherichia coli DNA polymerase III epsilon subunit increases Moloney murine leukemia virus reverse transcriptase fidelity and accuracy of RT-PCR procedures.

Authors:  Bahram Arezi; Holly H Hogrefe
Journal:  Anal Biochem       Date:  2006-10-30       Impact factor: 3.365

6.  Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Authors:  Dengli Hong; Rajeev Gupta; Philip Ancliff; Ann Atzberger; John Brown; Shamit Soneji; Joanne Green; Sue Colman; Wanda Piacibello; Veronica Buckle; Shinobu Tsuzuki; Mel Greaves; Tariq Enver
Journal:  Science       Date:  2008-01-18       Impact factor: 47.728

7.  Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance.

Authors:  Chunlin Wang; Yumi Mitsuya; Baback Gharizadeh; Mostafa Ronaghi; Robert W Shafer
Journal:  Genome Res       Date:  2007-06-28       Impact factor: 9.043

8.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

9.  Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.

Authors:  Thomas O'Hare; Christopher A Eide; Michael W N Deininger
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

10.  DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations.

Authors:  Christian Hoffmann; Nana Minkah; Jeremy Leipzig; Gary Wang; Max Q Arens; Pablo Tebas; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

View more
  178 in total

1.  Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.

Authors:  Katerina Machova Polakova; Vojtech Kulvait; Adela Benesova; Jana Linhartova; Hana Klamova; Monika Jaruskova; Caterina de Benedittis; Torsten Haferlach; Michele Baccarani; Giovanni Martinelli; Tomas Stopka; Thomas Ernst; Andreas Hochhaus; Alexander Kohlmann; Simona Soverini
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-04       Impact factor: 4.553

2.  High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment.

Authors:  Aaron C Logan; Hong Gao; Chunlin Wang; Bita Sahaf; Carol D Jones; Eleanor L Marshall; Ismael Buño; Randall Armstrong; Andrew Z Fire; Kenneth I Weinberg; Michael Mindrinos; James L Zehnder; Scott D Boyd; Wenzhong Xiao; Ronald W Davis; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

4.  What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics.

Authors:  Christian Gabriel; Stephanie Stabentheiner; Martin Danzer; Johannes Pröll
Journal:  Transfus Med Hemother       Date:  2011-09-25       Impact factor: 3.747

Review 5.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

Review 6.  New tools for classification and monitoring of autoimmune diseases.

Authors:  Holden T Maecker; Tamsin M Lindstrom; William H Robinson; Paul J Utz; Matthew Hale; Scott D Boyd; Shai S Shen-Orr; C Garrison Fathman
Journal:  Nat Rev Rheumatol       Date:  2012-05-31       Impact factor: 20.543

Review 7.  The influence of subclonal resistance mutations on targeted cancer therapy.

Authors:  Michael W Schmitt; Lawrence A Loeb; Jesse J Salk
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 8.  The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.

Authors:  Anna Gazzola; Claudia Mannu; Maura Rossi; Maria Antonella Laginestra; Maria Rosaria Sapienza; Fabio Fuligni; Maryam Etebari; Federica Melle; Elena Sabattini; Claudio Agostinelli; Francesco Bacci; Carlo Alberto Sagramoso Sacchetti; Stefano Aldo Pileri; Pier Paolo Piccaluga
Journal:  Ther Adv Hematol       Date:  2014-04

Review 9.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

10.  Genome-wide mutational diversity in an evolving population of Escherichia coli.

Authors:  J E Barrick; R E Lenski
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.